Matches 1 - 20 out of 20


Match Document Document Title
DE102015214603B4 Phosphorus containing aminoglycoside salts  
Compound of Formula 1 wherein the aminoglycoside is selected from the group of aminoglycoside or aminoglycoside group-containing antibiotics, where y is selected from 0.1 to 20, where n is...
DE102015214603A1 Phosphorus-containing aminoglycoside salts  
The object is to provide aminoglycoside compounds which ensure a sustained release of aminoglycoside over clinically relevant periods in therapeutically effective concentrations. Aminoglycoside...
DE102011112496A1 4-methylcatechol derivatives and their use  
The invention relates to phenoxy derivatives with glycosidically bound sugar residues, pharmaceutical compositions with such compounds, uses of such compounds and compositions and processes for...
DE102005013380A1 extraction process  
The This invention relates to a process for the preparation of Tiliroside or Tiliroside-containing extracts from parts of a plant, selected from the family Sterculiaceae, corresponding extracts...
DE102005005054A1 Hydrophilic bioquinone compound, processes for their preparation and their use  
It is a compound having a bioquinone bound to a sugar, a process for their preparation, a composition comprising said compound and the use of this compound or composition for the manufacture...
DE102004058449A1 tetrahydropyran  
New Compounds of the formula I, whereinT, E, R, R ', R' ', R1, R2 and R2 ' the meanings given in claim 1 have,useful as antidiabetics.
DE102004012676A1 New glucopyranosyl-substituted benzene derivatives are sodium-dependent glucose cotransporter inhibitors, useful for treating e.g. metabolic disorders (type 1 and type 2 diabetes mellitus or metabolic acidosis)  
Glucopyranosyl-substituted benzene derivatives (I) and their tautomers, sterioisomers andsalts are new. Glucopyranosyl-substituted benzene derivatives of formula (I) and their tautomers,...
DE19949284A1 Chiral compound and its use as chiral dopants for the preparation of cholesteric-liquid crystalline compositions  
Use of compounds of the general formula I, DOLLAR F1 in which the substituents have the meaning explained in the description, as chiral dopants for nematic or cholesteric liquid crystals to...
DE19942864A1 New O-aminoalkyl monosaccharide derivatives useful for control of bacterial, especially mycobacterial, and fungal infections  
O-Aminoalkyl monosaccharide derivatives (I) are new. O-Aminoalkyl monosaccharide derivatives of formula (I), their enantiomers, diastereomers, enantiomer mixtures, diastereomer mixtures and salts...
DE19844924A1 Immobilized cells of Actinoplanes acarbosefaciens SE 50/110, immobilization and use of immobilized system for preparing acarbose  
The invention relates to immobilised cells of Actinoplanes acarbosefaciens, for example SE 50/110 (DSM 12110), a method for their immobilisation by embedding in calcium alginate and the use of the...
DE19720312A1 Preparation with increased in vivo compatibility  
A preparation containing a $ A glycosyl-Y [-C (= Y) -X-] ↓ p ↓ -W (R) ↓ n ↓ -XC (= Y) active ingredient, sugar or sugar alcohol, divalent ions and a pharmaceutical compatible carrier has improved...
DE19643764A1 Glycoconjugates of modified camptothecin derivatives (20-0-link)  
Disclosed are glycoconjugates from modified camptothecin derivates, where at least a glucidic component is linked to the 20-hydroxyl group of a camptothecin derivate. Also disclosed are their...
DE19625269A1 Acarviosyl transferase from Actinoplanes sp. SE 50/110 and mutants, process for the production and the use of Acarviosyl transferase in converting acarbose homologues into acarbose, for preparing acarbose homologues and stem optimization  
The invention relates to acarviosyltransferase from actinomycetes, mainly from Actinoplanes sp. SE 50/110 and its mutants, a method for isolating, purifying and characterizing the enzyme,...
DE4305249A1 Galactosylbrefeldin A, a metabolite with pharmacological action, a process for its preparation and its use  
Published without abstract.
DE4236237A1 Prodrugs, their preparation and use as medicaments  
Substrate-spacer drug compounds (prodrugs), their preparation and their use as medicaments are described.
DE4224781A1 (ALPHA) -GLYCOSYLQUERCETINE, PROCESS FOR THEIR PRODUCTION AND USE  
A novel alpha -glycosyl quercetin, wherein equimolar or more D-glucose residues are attached to quercetin via the alpha -bond, has a satisfiable water-solubility, light tolerance and stability,...
DE4204889A1 Prepn. of sialoglycosyl cpds. - including cpds. useful in synthesis of ganglioside(s) and saccharide chain-antigens  
Prepn. of O-glycosyl cpds. (I) of sialic acid comprises reaction of a thioglycoside (II) of sialic acid, in the presence of N-iodosuccinimide (III) and trifluoromethane-sulphonic acid (IV), with a...
DE4009634A1 New 1-O-alkenoic acid ester(s) of carbohydrate(s) - used as glycosyl donors in synthesis of glycoside(s) and saccharide(s)  
1-O-alkenoic acid esters of carbohydrates of formula R-O CO-R1-CR2=CR3R4 are new. In (I), R = a carbohydrate gp. bonded via an anomeric C and protected on the hydroxyl and opt. amino gps. by acyl,...
DE3942355A1 N- AND O-SUBSTITUTED aminophenol, INTERMEDIATES FOR THEIR PRODUCTION, THEIR USE AS hydrolase, CORRESPONDING DETERMINATION PROCESS AND HERE FOR SUITABLE DIAGNOSTIC AGENTS  
The invention relates to the use of N- and O-substituted aminophenol derivatives as hydrolase substrates, to a corresponding determination method and diagnostic agent suitable therefor, and to...
DE3935016A1 Glycosyl ETOPOSIDE-PRODRUGS, PROCESS FOR PREPARING THEM AND THEIR USE IN COMBINATION WITH functionalized TUMOR SPECIFIC ENZYME CONJUGATES  
The present invention relates to glycosyl-etoposide prodrugs, Process for their preparation and their use in combination with functionalized tumor-specific enzyme conjugates for the treatment of...

Matches 1 - 20 out of 20